Lori A. Daiello, PharmD, BCPP
President, Pharmacotherapy Solutions
Geriatric Psychopharmacology Specialist
Providence, Rhode Island
Robert B. Santulli, MD
Associate Professor of Psychiatry
Dartmouth Medical School
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Pharmacists: 1.0 Contact Hour (0.1 CEU)
Nurses: 1.2 contact hours (based on a 50-minute hour) Medium
This program was originally presented as a live audioconference series in September and October of 2006. If you received CPE or CE credit for the audioconference, you are not eligible to receive credit through this online program.
Numerous studies have indicated that both anxiety and depressive disorders are under recognized and under treated in the long term care and community-dwelling elderly populations. Anxiety is a very prevalent psychiatric disorder among older adults. The prevalence of anxiety disorders has been estimated at 10.2%, with generalized anxiety disorder being the most common diagnosis at 7.3%. Anxiety disorders often result in severe emotional distress, which can lead to worsening of underlying medical illness, increased pain symptoms, decreased functioning, and unnecessary use of medications.
Depression is also common in the elderly. Some studies have shown that up to 15% of older Americans experience depression at some time, and the prevalence is significantly greater among nursing home residents. Anxiety and depression often co-exist in elderly individuals. Untreated or suboptimally treated depression negatively impacts medical comorbidity, cognition, and independence in activities of daily living.
Healthcare professionals who treat elderly individuals in both community and long term care settings need to recognize the signs and symptoms of depression and anxiety in the elderly. Clinicians also need to be familiar with basic anxiety and depression evaluation tools and to understand available treatment options. This educational program will examine current clinical evidence to assist clinicians in recognizing depression and anxiety in elderly individuals and selecting appropriate therapies.
. Target Audience
This program has been developed specifically for pharmacists and nurses who care for patients with depression and anxiety in the long-term care setting.
Upon completion of this educational activity, the participant should be able to:
Review the causes, signs, and symptoms of depression and anxiety in the elderly
Discuss diagnostic tools for depression and anxiety that are useful in elderly populations
Outline the therapeutic options that have been shown to be most beneficial for depression and anxiety treatment
In accordance with the guidelines set forth by the Accreditation Council for Pharmacy Education, it is the policy of the American Society of Consultant Pharmacists to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speakerĻs interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Lori A. Daiello, PharmD, BCPP, has served as a consultant for Abbott, Eli Lilly and Company, and Forest Pharmaceuticals, Inc. She has been a member of the speakerís bureau for Abbott, AstraZeneca, Eli Lilly and Company, and Forest Pharmaceuticals, Inc.
Robert B. Santulli, MD, has been a member of the speakerís bureau for AstraZeneca, Eisai Inc, Forest Pharmaceuticals, Inc, Novartis, Ortho-McNeil, Inc, and Pfizer Inc.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Credit Statements
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program (ACPE # 203-999-06-086-H01) was developed by ASCP and is approved for 1.0 Contact Hour (0.1 CEU).
NADONA/LTC is an approved provider of continuing nursing education by Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Centerís Commission on Accreditation #1087. This program provides 1.2 contact hours (based on a 50-minute hour) by NADONA/LTC.
Participants must successfully complete the post-test (70% or higher) and submit an evaluation to receive credit. Commercial Support Statements
Supported by an educational grant from Forest Pharmaceuticals, Inc.
Please turn off all pop-up blockers to assure access to the educational activity.
Click on the "Start program" icon. If you are not already logged in to the site, this will bring you to the login/registration page where you will be able to register as a new cmecorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
Complete the short survey and click on "done."
The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. This activity will require approximately 60 minutes to complete.
After the program has finished, click on the "Post-test" button. Complete the short survey and click on "done."
Instructions for completing and submitting the post-test and program evaluation are provided on the post-test screen. A credit certificate will be awarded for a score of 70% or better and may be printed immediately after passing the post-test.
None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this activity are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the American Society of Consultant Pharmacists, the National Association of Directors of Nursing Administration in Long-Term Care, or Forest Pharmaceuticals, Inc. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patientsí conditions and possible contraindications or risks or without a review of any applicable manufacturerís product information and comparison with the recommendations of other authorities.